Live feed
Filing
SCHEDULE 13D/A
SCHEDULE 13D/A0000947871-25-000086·ORBIMED ADVISORS LLC
Schedule 13D ownership disclosure
TRAWS PHARMA INC
Common Stock · CUSIP: 68232V884
Event date: 2024-12-31
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- ORBIMED ADVISORS LLCReported CIK 0001055951
Shares: 760,824.00 · Class: 19.9%
- OrbiMed Capital GP VIII LLCReported CIK 0001845804
Shares: 760,824.00 · Class: 19.9%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000947871-25-000086
- Form type
- SCHEDULE 13D/A
- Filer
- ORBIMED ADVISORS LLC
- CIK
- CIK 1055951
- Filed
- Jan 29, 2025
- Reporting period
- Dec 31, 2024
- Description
- Schedule 13D beneficial ownership